REFINeAI-Supported Diagnostic Accuracy Improvement in Nephrology
AI suggestion
Disease
+ Pathologic Processes
+ Pathological Conditions, Signs and Symptoms
Diagnostic Study
Summary
Study start date: November 20, 2025
Actual date on which the first participant was enrolled.This study is all about improving the diagnosis of kidney-related diseases, also known as nephrology cases. It explores whether providing doctors with real-time diagnostic suggestions from a high-performing AI model, specifically GPT-5, can enhance their diagnostic accuracy, confidence, and efficiency. The study is important because it could potentially revolutionize the way nephrology diagnoses are made, leading to improved patient care and addressing current challenges in this field. The study involves medical students, residents, fellows, and practicing physicians. Participants are divided into two groups: one group receives AI support, while the other group does not. Participants in both groups are presented with 10 nephrology cases to solve, and they can complete these cases over multiple sessions. In the AI-supported group, participants first provide their initial diagnoses and confidence ratings without AI assistance. Then, they are shown GPT-5's diagnostic suggestions, after which they can revise their diagnoses once. In the control group, participants view each case and provide up to three diagnoses followed by a confidence rating. The study measures initial and final diagnoses, confidence ratings, completion times, and participant demographic variables. The primary outcome is the diagnostic accuracy with and without AI support.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.100 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Diagnostic Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalStudy Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location